Vol. 7 (04) pp. 83-93 DOI: 10.21474/IJAR01/8794

CLINICAL AND BIOCHEMICAL EVALUATION OF THYMOQUINONE GEL IN THE TREATMENT OF CHRONIC PERIODONTITIS.

and
  • Lecturer of Oral Medicine, Oral Diagnosis and Periodontology, Faculty of Dentistry, Minia University, Egypt.
  • Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Egypt.
  • Department of Clinicalpharmacy, Faculty of Pharmacy, Deraya University, Minia, Egypt.
87 Downloads 244 Views
Crossref

Download Full Paper (PDF)

Abstract

Aim of study: toinvestigate the effect of Thymoquinone gel on the clinical periodontal parameters as well as the level of IL-1β and total anti-oxidant capacity levels in gingival crevicular fluid of chronic periodontitis patients. Patients and methods: This study was conducted on 68 subjects of both sexes with age ranged 25-58 years old. 48 patients were clinically diagnosed with moderate to severe chronic periodontitis. The 68 subjects were grouped into three groups; Group I (24 patients): received non-surgical periodontal therapy and Thymoquinone gel (0.1 % w/w), Group II (24 patients): received only non-surgical periodontal therapy and Group III: 20 healthy subjects (control group). The clinical parameters including plaque index (PI), gingival index (GI), probing depth (PD) and clinical attachment level (CAL) as well as the level of IL-1β and total anti-oxidant capacity levels in gingival crevicular fluid were recorded at baseline (prior to treatment) and at weeks 4 and 12 after treatment. Results: Groups I and II exhibited statistically significant differences in all clinical and biochemical parameters compared to baseline. Significant improvement in group I was detected at 4 weeks interval regarding biochemical parameters when compared to group II. Conclusion:non-surgical periodontal therapy improves all clinical and biochemical parameters in both groups significantly. Adjunctive use of thymoqinon gel improve the biochemical parameters significantly after 4 weeks only.

Keywords

Article Analytics

References

  1. ADRIAENS, P. A. & ADRIAENS, L. M. (2004). Effects of nonsurgical periodontal therapy on hard and soft tissues. Periodontology 2000, 36, 121-145.
  2. Alam S, Ueki K, Nakagawa K, et al. (2009) Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: An immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod;107:22-29.
  3. Alkharfy, K.M.; Ahmad, A.; Khan, R.M.; Al-Shagha, W.M. (2015) Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model.? J. Drug Metab. Pharmacokinet.,?40, 319?323.
  4. Baltacıoğlu E, Yuva P, Aydın G, Alver A, Kahraman C, Karabulut E et al. (2014) Lipid peroxidation levels and total oxidant/antioxidant status in serum and saliva from patients with chronic and aggressive periodontitis. Oxidative stress index: a new biomarker for periodontal disease? J Periodontol ;85(10):1432-41.
  5. Baser U, Gamsiz-Isik H, Cifcibasi E, Ademoglu E, Yalcin F (2015) Plasma and salivary total antioxidant capacity in healthy controls compared with aggressive and chronic periodontitis patients. Saudi Med J 36(7):856?861.
  6. Battino M, Gorini A, Villa RF, Genova ML, Bovina C, Sassi S et al.(1995) Coenzyme Q content in synaptic and non synaptic mitochondria from different brain regions in ageing rats. Mech Ageing Dev:78:173-87.
  7. Bendyk A, Marino V, Zilm PS, Howe P, Bartold PM. (2009) Effect of dietary omega-3 polyunsaturated fatty acids on experimental periodontitis in the mouse. J Periodontal Res;44:211?216.
  8. Bergmann A, Deinzer R.(2008) Daytime variations of interleukin-1beta in gingival crevicular fluid. Eur J Oral Sci.; 116(1):18-22.
  9. Brock GR, Butterworth CJ, Matthews JB, Chapple IL.(2004) Local and systemic total antioxidant capacity in periodontitis and health. J ClinPeriodontol; 31:515- 521.
  10. Brown, M. & Gilbert, P. (1993) Sensitivity of biofilms to antimicrobial agents. Journal of Applied Bacteriology 74 (suppl.), 87S?
  11. Chapple IL, Brock GR, Eftimiadi C, Matthews JB.(2002) Glutathione in gingival crevicular fluid and its relation to local antioxidant capacity in periodontal health and disease. MolPathol; 55:367-373.
  12. Chapple, I. L., Mason, G. I., Garner, I., Matthews, J. B., Thorpe, G. H., Maxwell, S. R., et al. (1997). Enhanced chemiluminescent assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid. Ann. Clin. Biochem. 34 (Pt 4), 412?421.
  13. Chaudhari AU, Byakod GN, waghmare PF, Krarhadkar VM (2011) correlation level of IL-1β in gingival crevicular fluid to the clinical. parameters of chronic periodentitis. Journal of contemporaryDental practice; 12(1):52-59.
  14. Chevion M, Berenshtein E, Stadtman ER. (2000) Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic Res.;33 Suppl:S99-108.
  15. Di Paola R, Mazzon E, ZitoDet al. (2005)Effects of Tempol, a membrane-permeable radical scavenger, in a rodent model periodontitis. J ClinPeriodontol ;32:1062?1068.
  16. Halliwell B. (1993) The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis; 1 (suppl.):118?126.
  17. Hou LT, Liu CM, Rossomando EF.(1995) Crevicular interleukin-1beta in moderate and severe periodontitis patients and the effect of phase I periodontal treatment. J Clin Periodontol;22:162.
  18. Kara MI, Erciyas K, Altan AB, et al. (2012) Thymoquinone accelerates new bone formation in the rapid maxillary expansion procedure. Arch Oral Biol.;57:357?363.
  19. Lamont RJ, Jenkinson LRJ. (1998) Life below the gum line: pathogenic mechanisms of Porphyromonasgingivalis. MicrobiolMolBiol Rev; 62:1244?63.
  20. L? YJ, Liu CM, WongMY, Hou LT, et al. (1999). Interleukin 1beta-secreting cells in inflamed gingival tissue of adult periodontitis patients. Cytokine; 11: 626-633
  21. Lukasz Gilowski.(2014) Amount of interleukin-1β and interleukin-1 receptor antagonist in periodontitis and healthy patients. Archives of Oral Biology; 59(7):729-734.
  22. M Mogi, J Otogoto,N Ota, H Inagaki, M Minami,K Kojima.(1999) Interleukin 1β, interleukin 6, β2-microglobulin, and transforming growth factor-α in gingival crevicular fluid from human periodontal diseaseArchives of Oral Biology.;Volume 44, Issue 6, Pages 535? 539.
  23. A. Randhawa and M. S. Al-Ghamdi, (2002) ?A review of the pharmacotherapeutic effects of Nigella sativa,? Pakistan Journal of Medical Research, vol. 41, pp. 77?83.
  24. A. Randhawa and M. S. Al-Ghamdi,(2002) ?A review of the pharmacotherapeutic effects of Nigella sativa,? Pakistan Journal of Medical Research, vol. 41, pp. 77?83.
  25. Macnee W, Rahman I. (1999) Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am J RespCrit Care Med;160:S58? S65.13.
  26. Mapp PI, Grootveld MC, Blake DR. (1995) Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull; 51:419?436.
  27. Mariod, R. M. Ibrahim, M. Ismail, and N. Ismail, (2009) ?Antioxidant activity and phenolic content of phenolic rich fractions obtained from black cumin (Nigella sativa) seedcake,? Food Chemistry, vol. 116, no. 1, pp. 306?312.
  28. Maxwell SR, Dietrich T, Chapple I(2006)L. Prediction of serum total antioxidant activity from the concentration of individual serum antioxidants. ClinChimActa ;372:188-194.
  29. McGuire, M. K. & Nunn, M. E. (1999) Prognosis versus actual outcome. IV. The effectiveness of clinical parameters and IL-1 genotype in accurately predicting prognoses and tooth survival. J Periodontol70, 49?56.
  30. Mostafa, M., E. Alaaeldin, et al. (2018). "Optimization and Characterization of Thymoquinone-Loaded Liposomes with Enhanced Topical Anti-inflammatory Activity." AAPS PharmSciTech 19(8): 3490-3500.
  31. Nader MA, El-Agamy DS, Suddek GM.(2010) Protective effects of propolis and thymoquinone on development of atherosclerosis in cholesterol-fed rabbits. Arch Pharm Res.;33:637?643.
  32. Orozco A, Gemmell E, Bickel M, Seymour GJ.(2006) Interleukin-1 b, interleukin-12 and inter- leukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis .Oral Microbiol Immunol.;21: 256 - 260.
  33. Pavlica Z, Petelin M, Nemec A, Erzen D, Skaleric .(2004) Measurement of total antioxidant capacity in gingival crevicular fluid and serum in dogs with periodontal disease. Am J Vet Res;65:1584-1588.
  34. Pihlstrom BL, Michalowicz BS, Johnson NW. (2005) Periodontal disease. Lancet;366:1809?20.
  35. Ragheb, A. Attia,W. S. Eldin, F. Elbarbry, S. Gazarin, and A. Shoker, (2009) ?The protective effect of thymoquinone, an anti-oxidant and anti-inflammatory agent, against renal injury: a review,? Saudi Journal of Kidney Diseases and Transplantation, vol. 20, no. 5, pp. 741?752.
  36. Reher VG, Zenobio EG, Costa FO, Reher P, et al. (2007) Nitric oxide levels in saliva increase with severity of chronic periodontitis. J. Oral Sci.;49: 271-276.
  37. Salmani, J.M.; Asghar, S.; Lv, H.X.; Zhou, J.P. (2014) Aqueous solubility and degradation kinetics of the phytochemical anticancer thymoquinone; probing the effects of solvents, pH and light.?Molecules,?19, 5925?5939.
  38. Sculley DV, Langley-Evans SC (2003) Periodontal disease is associated with lower antioxidant capacity in whole saliva and evidence of increased protein oxidation. ClinSci (Lond) 105(2):167?172. doi:10.1042/CS20030031
  39. Stashenko P, Fujiyoshi P, Obernesser MS, Prostak L, Haffajee AD, Socransky SS. (1991) Levels of interleukin 1 beta in tissue from sites of active periodontal disease. J Clin Periodontol.;18:548-54.
  40. Allahghadri, I. Rasooli, P. Owlia et al.,(2010) ?Antimicrobial property, antioxidant capacity, and cytotoxicity of essential oil from cumin produced in Iran,? Journal of Food Science, vol. 75, no. 2 pp. H54?H61.
  41. Taka E, Mazzio EA, Goodman CB, et al.(2015) Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells. J Neuroimmunol;286:5?12.
  42. Teng YT. (2003) The role of acquired immunity and periodontal disease progression. Crit Rev Oral Biol Med;14:237?252.
  43. Teng YT. (2006) Protective and destructive immunity in the periodontium: Part 1 - innate and humoral immunity and the periodontium. J.Dent. Res.; 85: 198-208.
  44. Tonetti, M. S. (1997) The use of topical antibiotics in periodontal pockets. In: Proceedings of the 2nd European Workshop on periodontology, eds. Lang, N. P., Karring, &Lindhe, J. Quintessence Publ.: Berlin.pp 78?109.
  45. Torumtay G, Kırzıoğlu FY, ?zt?rkTongu? M, Kale B, Calapoğlu M, Orhan H. (2016) Effects of periodontal treatment on inflammation and oxidative stress markers in patients with metabolic syndrome. J Periodontal Res. 51(4):489-98.

How to Cite This Article

Ahmed Abdallah Khalil and Eman Alaaeldin. (2019); CLINICAL AND BIOCHEMICAL EVALUATION OF THYMOQUINONE GEL IN THE TREATMENT OF CHRONIC PERIODONTITIS., Int. J. of Adv. Res., 7 (04), 83-93, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/8794

Corresponding Author

Ahmed Abdallah Khalil

Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.